Actualités réglementaires
11 sept. 2026•1 min de lecture
FDA Approves NESHER PHARMS Metoprolol Succinate Extended‑Release ANDA076640
NESHER PHARMS received FDA approval (submission AP) for ANDA076640 covering Metoprolol Succinate extended‑release tablets (200 mg and 100 mg equivalents), though both products are listed as discontinued.
Actualités réglementaires
10 sept. 2026•1 min de lecture
FDA Grants Approval for Metoprolol Tartrate Injectable (ANDA078085) by Hospira
The FDA has approved Hospira’s Metoprolol Tartrate injectable (ANDA078085), an intravenous prescription drug with a 1 mg/mL strength.
Actualités réglementaires
5 sept. 2026•1 min de lecture
FDA Approves ANDA078889 for Metoprolol Succinate Extended‑Release Tablets
The FDA has approved ANDA078889 for generic metoprolol succinate extended‑release tablets (100 mg and 200 mg) from several manufacturers.
Actualités réglementaires
3 sept. 2026•1 min de lecture
FDA Approves Actavis Labs Metoprolol Succinate Extended‑Release Tablets (ANDA 076862)
Actavis Labs FL Inc received FDA approval for its metoprolol succinate extended‑release tablets under ANDA 076862, covering a prescription 50 mg product and a discontinued 25 mg product.
Actualités réglementaires
3 sept. 2026•1 min de lecture
FDA Approves Lupin ANDA209272 for Metoprolol Succinate ER Tablets
FDA approved Lupin's ANDA209272 for metoprolol succinate extended‑release tablets in four strengths, all currently listed as discontinued.
Actualités réglementaires
30 août 2026•1 min de lecture
FDA Approves NESHER PHARMS Metoprolol Succinate ER Tablet (ANDA077176)
The FDA approved NESHER PHARMS' ANDA077176 for metoprolol succinate extended‑release tablets (50 mg eq). The product is listed as discontinued.
Actualités réglementaires
30 août 2026•1 min de lecture
NESHER PHARMS ANDA077779 for Metoprolol Succinate ER Tablet Approved by FDA
FDA approved ANDA077779 for metoprolol succinate extended‑release tablets from NESHER PHARMS; product listed as discontinued.